Real-life effectiveness of canakinumab in cryopyrin-associated periodic syndrome

201562 citationsJournal Articlebronze Open Access

Authors

Jasmin Kuemmerle‐Deschner · University Children's Hospital Tübingen

F Hofer · University Children's Hospital Tübingen

Theresa Endres · University Children's Hospital Tübingen

Birgit Kortus-Goetze · Philipps University of Marburg

Norbert Blank · University Hospital Heidelberg

Elisabeth Weißbarth‐Riedel · Universität Hamburg

Catharina Schuetz

Abstract

Real-life effectiveness of canakinumab in CAPS was significantly lower than in controlled trials. Treat-to-target strategies may improve the outcome of children and adults living with CAPS.

Topics & Keywords

Inflammasome and immune disorders Autoimmune and Inflammatory Disorders Research IL-33, ST2, and ILC Pathways

Publication Details

Published in: Lara D. Veeken

Volume 55, Issue 4, pp. 689-696

DOI: 10.1093/rheumatology/kev416

Field-Weighted Citation Impact: 3.26

Command Palette

Real-life effectiveness of canakinumab in cryopyrin-associated periodic syndrome

Authors

Abstract

Topics & Keywords

Publication Details